These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29719598)

  • 1. Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver.
    Zhang Y; Meng F; Sun X; Sun X; Hu M; Cui P; Vestin E; Li X; Li W; Wu XK; Jansson JO; Shao LR; Billig H
    Oncotarget; 2018 Apr; 9(26):18180-18197. PubMed ID: 29719598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.
    Petta S; Ciresi A; Bianco J; Geraci V; Boemi R; Galvano L; Magliozzo F; Merlino G; Craxì A; Giordano C
    PLoS One; 2017; 12(11):e0186136. PubMed ID: 29161258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism.
    Abruzzese GA; Heber MF; Ferreira SR; Velez LM; Reynoso R; Pignataro OP; Motta AB
    J Endocrinol; 2016 Jul; 230(1):67-79. PubMed ID: 27179108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
    Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
    Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
    Zhang Y; Sun X; Sun X; Meng F; Hu M; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
    Sci Rep; 2016 Jul; 6():30679. PubMed ID: 27461373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NFκB-mediated inflammation under conditions of hyperandrogenism and insulin resistance.
    Hu M; Zhang Y; Guo X; Jia W; Liu G; Zhang J; Cui P; Li J; Li W; Wu X; Ma H; Brännström M; Shao LR; Billig H
    Life Sci; 2019 Sep; 232():116681. PubMed ID: 31344428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic manifestations of women with polycystic ovary syndrome.
    Chen MJ; Ho HN
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats.
    Cui P; Hu W; Ma T; Hu M; Tong X; Zhang F; Shi J; Xu X; Li X; Shao LR; Billig H; Feng Y
    J Steroid Biochem Mol Biol; 2021 Apr; 208():105829. PubMed ID: 33513383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production.
    Hu M; Zhang Y; Guo X; Jia W; Liu G; Zhang J; Li J; Cui P; Sferruzzi-Perri AN; Han Y; Wu X; Ma H; Brännström M; Shao LR; Billig H
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E794-E809. PubMed ID: 30860876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
    Mannerås L; Jonsdottir IH; Holmäng A; Lönn M; Stener-Victorin E
    Endocrinology; 2008 Jul; 149(7):3559-68. PubMed ID: 18388196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
    Targher G; Rossini M; Lonardo A
    Endocrine; 2016 Feb; 51(2):211-21. PubMed ID: 26024975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
    Bohdanowicz-Pawlak A; Lenarcik-Kabza A; Brona A; Kuliczkowska-Płaksej J; Łaczmański Ł; Zaleska-Dorobisz U; Milewicz A
    Endokrynol Pol; 2014; 65(6):416-21. PubMed ID: 25554608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.
    Zheng SH; Li XL
    Gynecol Endocrinol; 2016; 32(3):177-83. PubMed ID: 26502288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.